ABCL

#1697
AbCellera Biologics Inc. - Common Shares
6.1 8 USD
+7.85%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
6.05
6.22
년간 변동
1.98
6.52
일일 변동
+7.85%
월간 변동
+59.28%
6달 변화
+71.19%
년간 변동율
+202.94%
이전 종가
5.7 3
Open
6.0 6
저가
6.0 5
High
6.2 2
양
1 579
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 1.89 B
  • Employee 562
  • Founded 2012
  • CEO Carl Hansen
  • Website www.abcellera.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00LLW2MF2
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-6.98
주가매출액비율
13.6

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

뉴스